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Keratinocyte Stem Cells
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Very primitive hematopoietic stem cells have been
identi¢ed as side population cells based on their ability
to e¥ux a £uorescent vital dye, Hoechst 33342. In this
study we show that keratinocytes with the same side
population phenotype are also present in the human
epidermis. Although side population keratinocytes have
the same dye-e¥uxing phenotype as bone marrow side
population cells and can be blocked by verapamil, they
do not express increased levels of the ABCG2 transpor-
ter that is believed to be responsible for the bone mar-
row side population phenotype. Because bone marrow
side population cells have stem cell characteristics, we
sought to determine if side population keratinocytes re-
present a keratinocyte stem cell population by compar-
ing side population keratinocytes with a traditional
keratinocyte stem cell candidate, label-retaining kerati-
nocytes. Flow cytometric analyses demonstrated that
side population keratinocytes have a di¡erent cell sur-
face phenotype (low b1 integrin and low a6 integrin
expression) than label-retaining keratinocytes and re-
present a unique population of keratinocytes distinctly
di¡erent from the traditional keratinocyte stem cell
candidate. Future in vivo studies will be required to ana-
lyze the function of side population keratinocytes in
epidermal homeostasis and to determine if side popula-
tion keratinocytes have characteristics of keratinocyte
stem cells. Key words: ABC transporters/Hoechst 33342/
integrins. J Invest Dermatol 121:1095 ^1103, 2003
H
ematopoietic stem cells (HSC) have been studied
intensively for clinical and research purposes, and
have provided model systems to understand stem
cell biology of renewing tissues (Bradford et al,
1997; Cheshier et al, 1999). Although a number of
transplantation studies have demonstrated that hematopoietic
progenitor stem cells express CD34, recent observations have
noted that a more primitive CD34-negative HSC population
may exist (Osawa et al, 1996; Bhatia et al, 1998; Zanjani et al,
1998). Dye e¥ux studies with Hoechst 33342 have identi¢ed a
minor fraction of CD34-negative HSC termed side population
(SP) cells on the basis of unique £uorescent properties (Goodell
et al, 1996). SP cells are highly enriched for long-term hemato-
poietic repopulation activity following transplantation, and are
present in multiple mammalian species (Goodell et al, 1997; Zhou
et al, 2001). A population of cells with an SP phenotype has also
been found in other tissues including muscle (Gussoni et al, 1999),
brain (Hulspas and Quesenberry, 2000), and pancreas (Lechner
et al, 2002), and may represent primitive progenitor cells in those
tissues. Inhibition of the SP phenotype by verapamil, presumably
by blocking dye e¥ux, suggests that the SP phenotype may result
from the expression of certain membrane pumps. The expression
of a member of the ABC transporter family, ABCG2 (also
known as BCRP or MXR), was recently reported to be upregu-
lated in SP cells isolated from mouse, rhesus monkey, and human
bone marrow, and is considered likely to be responsible for the
SP phenotype (Zhou et al, 2001; Scharenberg et al, 2002).
Since bone marrow SP cells probably represent primitive stem
cells, it would be interesting to determine if the epidermis of the
skin also contains SP keratinocytes (SP-KC) with the same phe-
notypic features. As a continuously renewing tissue of predomi-
nantly keratinocytes, the epidermis requires keratinocyte stem
cells (KSC) for tissue maintenance (Watt, 1998; Cotsarelis et al,
1999; Lavker and Sun, 2000; Taylor et al, 2000; Ghazizadeh and
Taichman, 2001). As unique cell surface markers for KSC have
not yet been de¢ned, however, it continues to be di⁄cult to pur-
ify and manipulate living KSC for biologic studies. If SP-KC ex-
ist in the epidermis, they may represent a candidate population
that possesses KSC behavior.
In the epidermis a small population of keratinocytes that
slowly cycle and retain a nucleoside label have been believed to
represent KSC (Bickenbach, 1981; Morris et al, 1985; Cotsarelis
et al, 1990; Bickenbach and Chism, 1998; Taylor et al, 2000). These
label-retaining cells (LRC) are detected by labeling keratinocytes
in vivo with bromodeoxyuridine (BrdU) over a long interval fol-
lowed by a chase period in the absence of BrdU. Rapidly divid-
ing basal cells (transit amplifying cells) dilute their nuclear label
with every cell division, and labeled keratinocytes that have
stopped dividing and entered the di¡erentiation pathway will be
lost from the skin surface. After the chase period, only non-
cycling or slowly cycling keratinocytes retain the nuclear label
and can be detected as BrdU-containing LRC. It is di⁄cult to
use LRC for biologic studies that require living cells, however,
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because the cells have to be ¢xed and permeabilized to detect the
BrdU label. Other methods that have been used to enrich for
KSC are the in vitro panning of keratinocytes based on rapid
adherence to extracellular matrices via high levels of integrins
including b1 (Jones and Watt, 1993; Jones et al, 1995; Bickenbach
and Chism, 1998), and £uorescence-activated cell sorting (FACS)
based on a speci¢c cell surface phenotype with high levels of b1
integrin (Jones andWatt, 1993) or high levels of a6 integrin with
low levels of the transferrin receptor CD71 (Li et al, 1998; Kaur
and Li, 2000; Tani et al, 2000). Cells collected by those methods
were enriched for LRC (Bickenbach and Chism, 1998; Tani et al,
2000).
Our goal here is to determine if SP-KC, with the same pheno-
type as bone marrow SP cells, exist in the epidermis, and then
characterize and compare themwith other epidermal cell popula-
tions, such as label-retaining KSC. Keratinocytes containing low
amounts of Hoechst 33342 dye have been described previously,
but were not de¢ned as SP cells because of their appearance on
FACS analysis and because of the methods used to isolate them
(Dunnwald et al, 2001; Liang and Bickenbach, 2002). Herein we
report that SP cells are present in human epidermis and contain
both keratinocytes and melanocytes. Interestingly, SP-KC do not
express the ABC transporters ABCG2 and P-gp that are
expressed in HSC (Chaudhary and Roninson, 1991; Baum et al,
1992; Zijlmans et al, 1995; Zhou et al, 2001; Scharenberg et al,
2002). Furthermore, our data show that SP-KC have cell surface
phenotypes di¡erent from those of classical KSC candidates, such
as label-retaining keratinocytes, suggesting that SP-KC represent
a distinctly di¡erent population.
MATERIALS AND METHODS
SP cell analysis Epidermal cell suspension was prepared from epidermal
sheets harvested from human newborn foreskins or foreskin grafts by
enzymatic treatment, and cells were resuspended at 106 cells per mL in
Keratinocyte-SFM (Invitrogen, Grand Island, NY) containing 1 mM
HEPES, penicillin, and streptomycin. Cells were preincubated at 371C for
15 min, and then incubated with 5 mg per mL Hoechst 33342 (Sigma
Chemical, St Louis, MO); the concentration of the Hoechst dye was
optimized by titration between 1 and 10 mg per mL (data not shown). For
a verapamil control, 50 mM verapamil (Sigma Chemical) was also added.
After an additional 371C 90 min incubation, propidium iodide (PI) was
added at 2 mg per mL for viability assessment, and cells were analyzed on
a FACSVantage cell sorter (BD Biosciences, San Jose, CA) according to the
method described by Goodell et al (1996). Brie£y, cells were excited with a
krypton ion laser emitting at 351 nm and emission was detected through
440/10 nm (‘‘Hoechst Blue’’) and 675/20 nm (‘‘Hoechst Red’’) narrow
bandpass ¢lters with signal separated by a 610 nm shortpass dichroic
mirror. Cells were then displayed in a Hoechst Blue versus Hoechst Red
dotplot to visualize the SP. All £uorescence data were collected in linear
mode and both acquired and analyzed with CellQuest £ow cytometry
acquisition/analysis software (BD Biosciences). For sorting experiments,
SP cells were sorted at 30 psi sheath pressure and approximately 49,000 Hz
drop drive frequency, at a rate of approximately 3000 cells per s. After the
sorting, SP cells were stained with antibodies as described below and
analyzed by a FACSCalibur £ow cytometer (BD Biosciences) equipped
with CellQuest software for at least 5000 events.
Characterization of di¡erent cell types in epidermal cell
suspensions To characterize the cell types in the SP, the sorted cells
were preincubated with a saturating concentration of anti-FcR (II/III; BD
Biosciences) and then incubated with antihuman CD45 monoclonal
antibody conjugated to allophycocyanin (APC; BD Biosciences). The cells
were ¢xed with Cyto¢x/Cytoperm bu¡er (BD Biosciences), and frozen at
801C in fetal bovine serum containing 10% dimethylsulfoxide. The cells
were thawed, ¢xed again with Cyto¢x/Cytoperm bu¡er, and serially
incubated with a melanocyte-speci¢c monoclonal antibody anti-MART-1
(clone M2-9 E3; Signet Pathology Systems, Dedham, MA) and rat anti-
mouse IgG2aþb secondary antibody conjugated to rhodamine
phycoerythrin (PE; BD Biosciences). For cytokeratin analysis, sorted cells
were ¢rst stained with anti-human CD45 monoclonal antibody conjugated
to PE (BD Biosciences), ¢xed as described above, and stained with anti-
MART-1 and Alexa Fluor 488 goat antimouse IgG2b secondary antibody
(Molecular Probes, Eugene, OR). Then the cells were stained with anti-
human cytokeratin 14 monoclonal antibody (clone LL002; Biomeda,
Foster City, CA) and Alexa Fluor 647 goat anti-mouse IgG3 secondary
antibody (Molecular Probes). Isotype controls used in analyses included
APC- or PE-conjugated mouse IgG1, puri¢ed mouse IgG2a/2b, and
puri¢ed mouse IgG3 (BD Biosciences).
Facs analysis for ABCG2, P-gp, CD34, and c-Kit expression on SP-
KC To determine the expression levels for ABCG2, P-gp, and CD34,
sorted cells were ¢rst stained with monoclonal antibodies speci¢c for each
molecule: BXP-21 for ABCG2 (Chemicon, Temecula, CA), MRK-16 for
P-gp (Kamiya Biomedical, Seattle, WA), and £uorescein isothiocyanate
(FITC) conjugated anti-human CD34 (BD Biosciences). To detect BXP-
21 and MRK-16, anti-mouse IgG2a secondary antibody conjugated to
Alexa Fluor 488 (Molecular Probes) was used. The cells were also stained
with APC-conjugated anti-human CD45, PI, and then analyzed by
FACSCalibur. For the analysis of c-Kit expression, sorted cells were
stained with PE-conjugated anti-human CD117 (BD Biosciences), APC-
conjugated anti-Annexin V (BD Biosciences), and 7-AAD, and incubated
in Annexin V Binding Bu¡er (BD Biosciences) at room temperature for
15 min. The cells were ¢xed with Cyto¢x/Cytoperm bu¡er, and serially
incubated with anti-MART-1 and Alexa Fluor 488 conjugated anti-mouse
IgG2b antibody (Molecular Probes). Isotype controls used in analyses
included puri¢ed mouse IgG2a (BD Biosciences) and PE-conjugated
mouse IgG1 (BD Biosciences). As positive controls for ABCG2, P-gp, and
CD34, a ABCG2-positive breast cancer cell line MCF-7 MX8 (generous
gift from Drs Robert Robey and Susan Bates at Medicine Branch, CCR,
NCI, NIH (Robey et al, 2001)), primary human ¢broblasts transduced with
a retroviral vector expressing MDR1 (Pfutzner et al, 1999), and puri¢ed
CD34-positive cells from human bone marrow (generous gift from Drs
Pieman Hematti and Cynthia Dunbar at Hematology Branch, NHLBI,
NIH), respectively, were used. The puri¢ed CD34-positive cells from
human bone marrow were also used as a positive control for the detection
of c-Kit.
Quantitative real-time RT-PCR Total RNA was prepared using the
RNAqueous-4PCR Kit (Ambion, Austin,TX) following the instructions
provided by the manufacturer, with an additional DNase treatment step.
Quantitative RT-PCRwas carried out using 50 ng of total RNA in a 50 mL
reaction with the aid of ABI PRISM 7700 sequence detection system
(Applied Biosystems, Foster City, CA). The sequence of primers and
probes used were as follows: ABCG2, forward primer, 50 -CAGGTCTGTT
GGTCAATCTCACA-30, reverse primer, 50 -TCCATATCGTGGAATG-
CTGAAG-30, probe, 6FAM-CCATTGCATCTTGGCTGTCATGGCTT-
TAMRA; MDR1, forward primer, 50 -AGAAAGCGAAGCAGTGGTTCA
-30, reverse primer, 50 -CGAACTGTAGACAAACGATGAGCTA-30, probe,
6FAM-TGGTCCGACCTTTTCTGGCCTTATCCA-TAMRA; MRP1, for-
ward primer, 50 -TCATGGTGCCCGTCAATG-30, reverse primer, 50 -
CGATTGTCTTTGCTCTTCATGTG-30, probe, 6FAM-ACCTGATAC
GTCTTGGTCTTCATCGCCA-TAMRA; MRP2, forward primer, 50 -
TGCAGCCTCCATAACCATGAG-30, reverse primer, 50 -GATGCCTG
CCATTGGACCTA-30, probe, 6FAM-AGAGAGAACAGCTTTCGTCG
AACACTTAGCC-TAMRA; MRP3, forward primer, 50 -CACACGGATC
TGACAGACAATGA-30, reverse primer, 50 -ACAGGGCACTCAGCTGTC-
TCA-30, probe, 6FAM-CCAGTCACCTATGTGGTCCAGAAGCAGTTTT-
AMRA; MRP4, forward primer, 50 -CGAGTAGCCATGTGCCATATGA-30,
reverse primer, 50 -GACTATCTGGCCTGTGGTTGTCTT-30, probe, 6FAM-
CCATGGCCATGTTACTAAGACGACGAAGTGCCTT-TAMRA; and
glyceraldehyde-3-phosphate dehydrogenase (GAPDH), forward primer,
50 -GAAGGTGAAGGTCGGAGTC-30, reverse primer, 50 -GAAGATGGT-
GATGGGATTTC-30, probe, JOE-CAAGCTTCCCGTTC-TCAGCC-
TAMRA. As positive controls for ABCG2 and MDR1, an ABCG2-posi-
tive breast cancer cell line MCF-7 MX8 (Robey et al, 2001) and primary
human ¢broblasts transduced with a retroviral vector expressing MDR1
(Pfutzner et al, 1999) were used, respectively. Total RNA from human
lung and liver (Ambion) were also used as controls. Relative expression
levels of ABC transporters were shown as DCT values standardized with
GAPDH expression levels using the following equation: DCT¼CT(ABC)
 CT(GAPDH).
Cell cycle analysis For cell cycle analysis, sorted cells were ¢xed in 70%
ethanol at 41C for 20 min, treated with 40 mg per mL RNase at 371C for
20 min, and resuspended in phosphate-bu¡ered saline (PBS) containing
2% fetal bovine serum and 3 mg per mL PI. Cells were analyzed on a
FACSCalibur £ow cytometer (BD Biosciences) and cell cycles were
calculated with ModFit software (Verity Software House,Topsham, ME).
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Detection of LRC To detect LRC in human epidermis, human
neonatal foreskins were grafted onto the back of nude mice.
Simultaneously, the animals were labeled with 100 mM BrdU solution
continuously for 6 wk at 0.4 mg per d (total dose 16.8 mg) using two
ALZET osmotic pumps (model 1002; Durect, Cupertino, CA) implanted
subcutaneously. During the labeling period, 0.01% O-tetradeca-
noylphorbol-13-acetate in petrolatum was topically applied to the grafts
on the second and fourth weeks. Eight weeks after cessation of labeling,
grafts were harvested, ¢xed in modi¢ed Carnoy’s (95% ethanol and
5% glacial acetic acid), and para⁄n embedded. Para⁄n-embedded
sections were dewaxed, rehydrated, and denatured with 4 M HCl once for
10 min and then for 20 min. The sections were neutralized with 0.1 M
sodium borate for 5 min, and washed once with PBS for 5 min and then
twice with PBS containing 10% fetal bovine serum for 10 min each. The
sections were incubated for 1 h with anti-BrdU-peroxidase (Fab fragments,
clone BMG-6H8; Roche Applied Science, Indianapolis, IN), diluted to be
0.5 U per mL with PBS containing 1% of bovine serum albumin. After
washing three times with PBS for 2 min each, the peroxidase conjugates
were detected using Vector VIP Substrate Kit (Vector Laboratories,
Burlingame, CA) according to the protocol provided by the manu-
facturer. All the staining processes were carried out at room temperature.
FACS analyses were performed using a BrdU Flow Kit (BD Biosciences).
For both immunohistochemistry and FACS analyses, samples prepared
from grafts that had not been labeled with BrdU were used as negative
controls.
FACS analysis for integrins and CD71 expression on LRC and
SP-KC To determine the levels of expression of b1 integrin, a6
integrin, and CD71 on LRC, SP-KC, and their controls, each population
was handled in the same way as follows. Cells were ¢rst stained with PE-
conjugated anti-human CD29 (b1 integrin), CD49f (a6 integrin), or CD71
monoclonal antibody (BD Biosciences), as well as with APC-conjugated
anti-human CD45 and anti-mouse CD45. They were then ¢xed with
Cyto¢x/Cytoperm (BD Biosciences), frozen at 80 1C, ¢xed again with
Cyto¢x/Cytoperm as described above, and stained with anti-MART-1.
Anti-MART-1 was detected by TriColor-conjugated goat anti-mouse
IgG2b secondary antibody (Caltag Laboratories, Burlingame, CA). BrdU-
positive LRC were detected using FITC-conjugated anti-BrdU antibody
supplied as part of the BrdU Flow Kit (BD Biosciences). To evaluate the
a6 integrin expression levels in un¢xed cells, epidermal cells were stained
with FITC-conjugated anti-human CD49f immediately after Hoechst dye
staining without any ¢xation, and evaluated for their a6 integrin
expression levels and Hoechst signals at the same time. Cells were
analyzed on a FACSCalibur £ow cytometer (BD Biosciences). Isotype
controls used in analyses included mouse IgG1, rat IgG2a, and mouse
IgG2a conjugated to PE, and mouse IgG1 conjugated to FITC.
BrdU pulse-labeling of cultured keratinocytes Keratinocytes
prepared from neonatal foreskins were cultured in Keratinocyte-SFM
(Invitrogen). For pulse-labeling with BrdU, cells were cultured in the
medium containing 0.3 mM BrdU for 3 h. The cells were then harvested
and stained with Hoechst dye as described above. Cells with dye-low
phenotype were sorted by FACSVantage and analyzed for their BrdU
contents using the method described above.
RESULTS
SP cells are present in human epidermis To determine if SP
cells are present in human epidermis, we analyzed epidermal cell
suspensions from human neonatal foreskin using the same
technique used for bone marrow SP detection (Goodell et al,
1996) with a minor modi¢cation (we used serum-free medium
instead of Dulbecco’s modi¢ed Eagle’s medium containing fetal
bovine serum). Flow cytometric analysis revealed a minor (0.3%
of the total epidermal cells in suspension) but distinct and
reproducible tail of SP cells analogous to bone marrow SP cells
(Fig 1A and data not shown). The formation of the epidermal SP
tail was blocked by verapamil treatment, again similar to the
block of bone marrow SP by verapamil (Fig 1B and data not
shown). We puri¢ed SP cells by FACS (Fig 1C, D) and sub-
jected them to further analyses. Since epidermal cell suspensions
contain not only keratinocytes but also melanocytes, Langerhans
cells, and lymphocytes, we wanted to determine the percentages
of these cells using the anti-melanocyte monoclonal antibody
anti-MART-1 and anti-human CD45 monoclonal antibody (Fig
1E, F, and Table I). Epidermal cell suspensions contained 5.1%
melanocytes and 1.3% CD45-positive Langerhans cells and
lymphocytes (Fig 1E; Table I, n¼ 9). By comparison, SP cells
contained 10.0% melanocytes and 1.1% CD45-positive cells (Fig
1F;Table I, n¼ 4).Therefore, epidermal SP cells were enriched 2-
fold for melanocytes. By gating out melanocytes and CD45-
positive cells, the resultant MART-1^/CD45^ population should
only contain a pure population of keratinocytes. A monoclonal
antibody speci¢c for cytokeratin 14, which is predominantly
expressed in basal keratinocytes and not in di¡erentiated keratino-
cytes, was used to characterize the MART-1^/CD45^ popula-
tions. All the cells in the MART-1^/CD45^ SP population, or
SP-KC, showed high levels of cytokeratin 14 expression (Fig 1G,
¢lled area) suggesting that the MART-1^/CD45^ SP population
contained only basal keratinocytes. The potential toxicity of
Hoechst 33342 on epidermal cells was assessed by incubating the
cells at 371C in the absence or presence of the dye and evaluating
the percentages of PI-positive dead cells by FACS. Whereas
unstained control cells showed 45.4%73.6% (n¼ 3) of PI-
positive cells, cells stained with the dye demonstrated 51.5%7
2.5% (n¼ 3) to be PI positive, indicating that Hoechst 33342 does
not signi¢cantly increase the percentage of PI-positive cells
(p¼ 0.11). Additionally, the total epidermal cells stained with
Hoechst 33342 were capable of forming large healthy keratino-
cyte colonies after 2 wk of in vitro culture (data not shown).
ABCG2 and MDR1 were not upregulated in epidermal SP
cells Since the dye e¥ux exhibited by bone marrow SP has
been attributed to ABCG2 (Zhou et al, 2001), a member of the
ABC transporter family, we wanted to determine if ABCG2
was also expressed by epidermal SP cells. Using a monoclonal
antibody reactive with ABCG2, no ABCG2 expression was
detected on the surface of epidermal SP cells (Fig 2I; positive
control shown in Fig 2A; isotype control shown in Fig 2E) or
on the surface of cells in the total epidermal cell preparation (data
not shown). We also assessed ABCG2 mRNA levels using
quantitative real-time RT-PCR and found that, although
ABCG2 protein is not detected by FACS, ABCG2 mRNAwas
expressed in the human epidermis (Fig 3B, C). Unlike bone
marrow SP cells, however, ABCG2 mRNAwas not upregulated
in epidermal SP cells (Fig 3B). Since MDR1, another member of
the ABC transporters, is known to be expressed on HSC
(Chaudhary and Roninson, 1991; Baum et al, 1992; Zijlmans et al,
1995), we analyzed the expression of MDR1 and its protein
product P-gp on epidermal SP cells. Flow cytometric analysis
showed no surface expression of P-gp on epidermal SP cells
(Fig 2J; positive control shown in Fig 2B; isotype control
shown in Fig 2F). Quantitative real-time RT-PCR showed the
absence of mRNA for MDR1 in total human epidermis, as well
as in SP and non-SP epidermal cells (Fig 3B, C).We also analyzed
the expression of other candidate ABC transporters (MRP1,
MRP2, MRP3, and MRP4) that can be expressed on the cell
surface and transport some of the same substrates as P-gp (Borst
et al, 2000; Gottesman et al, 2002). Quantitative real-time RT-
PCR demonstrated no upregulation of mRNA expression of
these transporters in epidermal SP cells (Fig 3B).
HSC-marker CD34 and c-Kit are not expressed by
epidermal SP cells Although CD34-positive stem cells are
present in bone marrow, and have been described in other
tissues (Lin et al, 1995; Omori et al, 1997; Beauchamp et al, 2000;
Crosby et al, 2001; Torrente et al, 2001), CD34 expression is
generally absent or low on bone marrow SP cells (Goodell et al,
1997). Since both CD34 expression and the SP phenotype have
been used as markers for stem cells, we wanted to determine if
epidermal SP cells express CD34. Flow cytometric analysis
using anti-CD34 monoclonal antibody demonstrated that
epidermal SP cells were negative for CD34 (Fig 2K; positive
control shown in Fig 2C; isotype control shown in Fig 2G).
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Since a tyrosine kinase receptor c-Kit is present in the majority of
bone marrow SP cells (Zhou et al, 2002), we evaluated the
expression of c-Kit on epidermal SP cells using a monoclonal
antibody against c-Kit. After gating out MART-1-positive
melanocytes, most of which were c-Kit positive, SP-KC were
shown to be negative for c-Kit (Fig 2L; positive control shown
in Fig 2D; isotype control shown in Fig 2H).
Increased percentages of SP cells are quiescent at G0^G1
phase We next performed a cell cycle analysis of epidermal SP
cells as previous studies demonstrated that bone marrow SP cells
were enriched for cells at the G0G1 phase (only 2% of SP cells
were at SG2/M, whereas 20% of total bone marrow cells were
at SG2/M), consistent with the slow cycling behavior of HSC
(Goodell et al, 1996). Cell cycle pro¢le analysis of epidermal cells
demonstrated that 12.1% 7 0.5% (n¼ 3) of cells in the total
Figure1. SP-KC are present in human epidermis. Hoechst £uorescence of human epidermal cell suspension reveals a verapamil-sensitive SP (A, in the
absence of verapamil; B, in the presence of verapamil). SP cells were sorted by FACS with high purity (C, before sorting; D, after sorting) for most of the
following analyses. Melanocytes (detected by anti-MART-1) and CD45-positive cells are analyzed in total epidermal cell suspension (E) and in £ow-sorted
epidermal SP cells (F). Cytokeratin 14 expression by MART-1^/CD45^ total keratinocytes (G, thick line) and by MART-1^/CD45^ SP-KC (G, ¢lled area).Thin
line shows isotype control. In order to facilitate the comparison of total keratinocytes to SP-KC, the relative peak height of SP-KC is emphasized.
Table I. Cell types in SP cells and LRC
Melanocytes Human CD45(þ ) cells
Total (fresh foreskin) 5.1þ0.4% (n¼ 9) 1.3þ 0.2% (n¼ 9)
SP (fresh foreskin) 10.0þ3.9% (n¼ 4) 1.1þ0.3% (n¼ 4)
Total (foreskin graft) 4.3þ 0.3% (n¼ 27) 0.2þ 0.1% (n¼ 6)
LRC (foreskin graft) 17.1þ3.3% (n¼17) 0.0þ 0.0% (n¼ 4)
Data are meanþ SEM.
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epidermal population were in the SG2/M phase after the
staining with Hoechst dye, whereas the epidermal SP contained
3.6%70.3% (n¼ 3) of cells in SG2/M (Fig 4). This indicates
that epidermal SP cells are also enriched for quiescent cells at
G0G1 phase (p¼ 0.0002). The epidermal SP population (Fig 4)
also contains melanocytes that are presumably noncycling. As
melanocytes represent 5% of epidermal cells and 10% of
epidermal SP cells (Table I), their removal from the G0G1 cell
counts would slightly increase the percentages of SG2/M cells
in both populations (12.1% to 12.7% for epidermal cells, and
3.6% to 4.0% for epidermal SP cells), and slightly decrease the
percentages of quiescent cells in G0G1.
LRC in the epidermis of human foreskin grafts Since bone
marrow SP cells were shown to behave as very primitive HSC,
one important issue is whether SP-KC represent or contain
KSC. To obtain human LRC that are believed to represent KSC
for comparison with SP cells, we grafted human neonatal
foreskins on the backs of nude mice and labeled the animals
with BrdU continuously for 6 wk using ALZET osmotic
pumps. At the end of the labeling period all the epidermal cells
were labeled with BrdU (Fig 5A, D; negative control data from
unlabeled graft shown in Fig 5C). After 8 wk of a postlabeling
chase period, only a few basal cells were detected as BrdU-
positive LRC (Fig 5B). Flow cytometric analysis consistently
showed 1%3% of the total epidermal population to be LRC,
412 wk post-labeling (Fig 5E), consistent with ¢ndings from
other investigators (Bickenbach and Chism, 1998). Human
epidermal cells could be distinguished from mouse cells by
histologic and FACS analyses using monoclonal antibodies
against human involucrin and HLA-A, B, C, respectively. The
number of melanocytes and CD45-positive cells in the human
LRC population were characterized with the same monoclonal
antibodies and method used for SP cell characterization (Table
I). Interestingly, melanocytes were also enriched in the LRC
population (17.1%73.3%; n¼17) compared to 4.3%70.3%
(n¼ 27) for total epidermal cells. Pure LRC keratinocytes were
isolated by gating out melanocytes and CD45-positive cells.
This population was compared with SP-KC.
A comparison of SP-KC and LRC keratinocytes In order to
determine if SP-KC represent or overlap LRC, we compared SP-
KC with LRC keratinocytes for expression of cell surface
molecules using speci¢c monoclonal antibodies. Because the
BrdU label in LRC is known to quench Hoechst 33342
£uorescence, yielding a false dye-low population, a direct
Figure 2. FACS analysis reveals no expression of ABCG2, P-gp, CD34, and c-Kit on epidermal SP cells. Positive control cells (thick line in A, B, C,
D) and SP cells puri¢ed by FACS (I, J, K, L) are analyzed using monoclonal antibodies against ABCG2, P-gp, CD34, and c-Kit. Isotype controls for positive
control cells are shown as thin lines in (A), (B), (C), and (D). Isotype controls shown in (E), (F), (G), and (H) are prepared with total epidermal cells.
Representative results from three sets of experiments are shown.
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comparison of SP-KC and LRC keratinocytes by FACS analysis
is not feasible. In other words, BrdU-labeled cells would appear
as dye-low cells even though they are not true SP cells. This
quenching e¡ect of BrdU can be demonstrated by measuring
the number of SP cells in both control and BrdU pulse-labeled
cultured keratinocytes (Fig 6). Whereas unlabeled control cells
showed only 0.3% SP cells (Fig 6A), BrdU-labeled cells
demonstrated increased numbers of dye-low cells within the SP
gate (1.5%; Fig 6B). Next, the BrdU-labeled cells shown in Fig
6(B) were analyzed by FACS for BrdU content (Fig 6C, D). The
£ow-sorted dye-low population (SP gate) was enriched with cells
of extremely high BrdU content (13.0%; Fig 6C) compared to
the FACS analysis of an equivalent number of events from the
total population of pulse-labeled cells (6.1%; Fig 6D). The data
indicate that cells labeled with BrdU exhibit a false dye-low
phenotype that mimics the SP phenotype.
Since the presence of LRC in the SP population cannot
be directly assessed, we instead compared the cell surface
phenotypes of SP cells and LRC. Epidermal cell suspensions
were prepared from fresh foreskins for SP cells and from BrdU-
labeled foreskin grafts for LRC, and stained for b1 integrin,
a6 integrin, CD71, and CD45. Cells were ¢xed twice,
permeabilized, and stained with anti-MART-1. All non-
keratinocytes were excluded by gating out MART-1-positive
cells and CD45-positive cells. BrdU-positive LRC keratinocytes
were shown to be b1 integrin-high, a6 integrin-high, and CD71-
low (Fig 7AC; ¢lled areas), consistent with previously reported
cell surface phenotypes of KSC candidate populations (Jones and
Watt, 1993; Jones et al, 1995; Li et al, 1998; Kaur and Li, 2000; Tani
et al, 2000). In contrast, SP-KC showed distinctly di¡erent and
non-overlapping expression pro¢les of b1 and a6 integrins
compared to LRC keratinocytes; SP-KC expressed only very
low levels of b1 and a6 integrins (Fig 7D, E; ¢lled areas). Since
SP cells were prepared from fresh foreskins and the LRC were
prepared from foreskin grafts placed on the backs of nude mice
for more than 3 mo, it is possible that di¡erent integrin
expression pro¢les between SP cells and LRC could be
attributed to di¡erent starting materials. To rule out this
possibility, we also determined the integrin expression pro¢les
of SP cells obtained from grafts that were not labeled with
BrdU. Signi¢cantly, the SP-KC from unlabeled grafts also
showed very low levels of b1 and a6 integrin expression (Fig
7G, H; ¢lled areas), consistent with the observation that SP-KC
have a distinctly di¡erent expression pro¢le from LRC
keratinocytes. Therefore, di¡erent integrin expression pro¢les
between SP cells and LRC were not attributable to di¡erent
starting materials. Additionally, the total epidermal cells from
unlabeled grafts demonstrated b1 integrin and a6 integrin
expression pro¢les similar to total epidermal cells from LRC
grafts (Fig 7A, B, G, H). In order to rule out ¢xation artifact,
the ¢nding of low a6 expression on SP cells was con¢rmed by
FACS analysis of un¢xed epidermal cells (Fig 7I). SP cells
demonstrated low levels of a6 integrin expression whereas non-
SP populations expressed higher levels of a6 integrin (Fig 7I).
DISCUSSION
In this study, we found that human epidermis contains a very
small and verapamil-sensitive SP-KC population similar to bone
marrow SP cells. Interestingly, the basis for the SP phenotype
does not appear to be due to a higher expression level of ABCG2
transporter as described for bone marrow SP cells. Because bone
marrow SP cells are biologically signi¢cant as a very primitive
population of HSC, we wondered if SP-KC represent or overlap
with the KSC population, and compared SP-KC with LRC, a
traditional KSC candidate. Surprisingly, our data indicate that
SP-KC represent a population that is distinctly di¡erent from the
LRC population.
Figure 3. Expression levels of ABC transporters are not upregulated
in epidermal SP cells. (A) Gates used to sort SP cells and non-SP cells by
FACS. (B) DCTvalues obtained by quantitative real-time RT-PCR standar-
dized by GAPDH. Note that the y axes of the graphs are reversed: a lower
DCT value means a higher level of gene expression. MDR1 expression is
absent in total epidermis, SP cells, and non-SP cells. Speci¢c positive con-
trols are used only for ABCG2 and MDR1. Each value is the average of
triplicate reactions. (C) Final products of quantitative real-time RT-PCR
are analyzed on 4% agarose gel. Representative results from at least three
sets of experiments are shown.
Figure 4. SP cells are enriched for quiescent cells at G0/G1 phase.
Cell cycle analyses of total epidermis (A) and SP cells (B). Representative
results from three sets of experiments are shown.
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Within the total epidermal cell suspension 0.3% of the cells
were detected as SP cells. This percentage is higher than that re-
ported for bone marrow SP cells (0.05%; Goodell et al, 1996), pos-
sibly re£ecting di¡erences in the two tissues. Also of interest is
the lower percentage of SP-KC (0.3%) compared to LRC kerati-
nocytes (1%3%) in epidermal cell suspensions, raising the pos-
sibility that SP-KC might be contained within the LRC
population. To see if this is the case, a direct comparison of SP
Figure 5. LRC are detected in BrdU-labeled human skin grafts. BrdU staining of skin sections immediately after labeling (A) and 8 wk post-labeling
(B). Arrows indicate BrdU-positive cells in the basal layer. FACS analyses of total keratinocytes from a non-labeled graft (C), a graft immediately after
labeling (D), and a graft 8 wk post-labeling (E). Representative results from 17 sets of experiments are shown.
Figure 6. BrdU labeling artifactually increases the number of dye-low cells exhibiting an SP phenotype. SP cells in control cultured keratino-
cytes (A). Increased numbers of dye-low cells in the SP gate following BrdU pulse-labeling of cultured keratinocytes for 3 h (B). Additional FACS analysis
was then performed on the BrdU pulse-labeled cells shown in (B) in order to measure the BrdU content in the sorted keratinocytes present in the SP gate
(C) and in the total pulse-labeled population (D). The SP gated population is signi¢cantly enriched for BrdU-labeled keratinocytes with large amounts of
BrdU label on a per cell basis (C), compared to BrdU-labeled keratinocytes in the total keratinocyte population (D).
SIDE POPULATION HUMAN KERATINOCYTES 1101VOL. 121, NO. 5 NOVEMBER 2003
cells and LRCwould be the most straightforward: SP cells would
be sorted by FACS out of a cell suspension that contains LRC,
and determined if they were enriched for the LRC. This ap-
proach is not feasible, however, because the BrdU label quenches
the £uorescence from Hoechst dye during FACS as shown in
Fig 6. Because of this quenching e¡ect, BrdU-positive LRC show
a false dye-low phenotype and will appear incorrectly as SP cells.
Instead, we utilized cell surface markers expressed on LRC,
and compared SP cells and LRC based on their cell surface phe-
notypes. As shown in Fig 7, SP-KC had distinctly di¡erent integ-
rin expression pro¢les compared to LRC keratinocytes. The data
indicate that SP-KC are a unique population of keratinocytes that
do not overlap with LRC keratinocytes, a traditional candidate
for KSC.To know if SP-KC could behave as primitive stem cells,
analogous to bone marrow SP cells (Goodell et al, 1996), it will be
necessary to assess their behavior in in vivo biologic assays (Kolod-
ka et al, 1998; Robbins et al, 2001; Kuhn et al, 2002).
SP cells have been found in bone marrow of a variety of mam-
malian species (Goodell et al, 1997; Zhou et al, 2001) and in various
tissues (Gussoni et al, 1999; Hulspas and Quesenberry, 2000; Lech-
ner et al, 2002). This is the ¢rst report describing SP cells in the
epidermis that are phenotypically similar to bone marrow SP
cells on FACS analysis. Previously, Dunnwald et al (2001) reported
a KSC candidate in mouse epidermis that was isolated also using
Hoechst 33342 dye. Using an in vitro repopulation assay system,
these investigators showed a high repopulation ability of the
dye-low population, suggesting their potential as KSC. Although
their dye-low mouse epidermal cells may overlap with SP cells,
they were not de¢ned as SP cells because the authors used a mod-
i¢ed method with speci¢cally de¢ned FACS gating that was dif-
ferent from the SP tail detection method originally described by
Goodell et al (1996), and because of the presence of BrdU (Dunn-
wald et al, 2001) that can cause a dye-low phenotype as described
earlier. Whether these di¡erent methods identify similar or
di¡erent keratinocyte populations remains to be determined. It
will also be interesting to know if those dye-low mouse cells
are sensitive to verapamil or any other pump inhibitors as SP
cells are.
Figure 7. LRC and SP-KC show distinctly
di¡erent and non-overlapping expression
pro¢les of b1 and a6 integrins by FACS.
Thin lines, isotype control; thick lines, total kera-
tinocytes; ¢lled areas, label-retaining keratino-
cytes (AC) or SP-KC (DH). In order to
facilitate the comparisons of total keratinocytes
to LRC (AC) and SP (DH) keratinocytes,
the relative peak heights of LRC and SP-KC
are emphasized. The levels of a6 integrin were
also assessed on un¢xed SP and non-SP popula-
tions (I). SP cells in epidermal suspensions de-
monstrate much lower a6 expression than non-
SP cells. Representative results from at least
three sets of experiments are shown.
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Although the verapamil sensitivity of SP-KC may be attribu-
ted to the dye e¥ux activity by one or more ABC transporters, it
is not clear yet which transporters are responsible for the Hoechst
33342 e¥ux in SP-KC. Identi¢cation of a speci¢c transporter is
important because it may represent a unique marker for SP-KC.
In bone marrow SP cells and murine muscle SP cells, ABCG2
appears to be responsible for the SP phenotype.We could not de-
tect any upregulation of ABCG2 in SP-KC, however. Addition-
ally, P-gp encoded by another member of the ABC transporter
gene family, MDR1, and expressed in HSC, was not present in
SP-KC.We also assessed the expression of four MRP members
that can be expressed on the cell surface and share common trans-
port substrates with P-gp (Borst et al, 2000; Gottesman et al,
2002), but none was upregulated in SP-KC. As there are at least
48 members of ABC transporters in human cells, a systematic ap-
proach to ¢nd responsible transporters, using high-throughput
analysis, is currently being pursued.
Exact homeostatic mechanisms that maintain the epidermis are
yet to be understood. One of the biggest hurdles for in vitro and in
vivo biological studies is our inability to purify living KSC. If fu-
ture analysis of SP-KC demonstrates progenitor cell activity,
these living SP-KC would be quite useful in understanding epi-
dermal homeostasis.
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